2026-06-10 10:33 |
Detailed record - Similar records
|
2026-06-10 10:32 |
Detailed record - Similar records
|
2026-06-10 10:27 |
[DZNE-2026-00601]
Journal Article
Steward, A. ; Dewenter, A. ; Hirsch, F. ; et al
ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner.
In Alzheimer's disease, carriage of the apolipoprotein E ε4 (ApoE4) risk allele is linked to faster tau accumulation at lower amyloid-PET levels, thereby accelerating disease progression. However, it remains unclear whether this ApoE4-facilitated transition from amyloidosis to tauopathy is mechanistically promoted by increased secretion of phosphorylated tau (ptau), a key intermediate that drives the amyloid-to-tauopathy transition, or alternatively by increased ptau-driven tau aggregation. [...]
Detailed record - Similar records
|
2026-06-08 15:55 |
Detailed record - Similar records
|
2026-06-08 15:53 |
Detailed record - Similar records
|
2026-06-08 15:51 |
[DZNE-2026-00598]
Journal Article
Dewenter, A. ; Bürger, K. ; Janowitz, D. ; et al
Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study.
We investigated how plasma biomarkers (phosphorylated tau 217 [ptau217], glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL]) relate to imaging markers of small vessel disease (SVD) and Alzheimer's disease (AD), and cognition in memory clinic patients.76 memory clinic patients underwent plasma biomarker assessment, neuropsychological testing, and 3T MRI. SVD burden was assessed using white matter hyperintensity (WMH) volume, mean skeletonized mean diffusivity (MSMD), and fiber density. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-06-08 15:39 |
Detailed record - Similar records
|
2026-06-08 15:36 |
[DZNE-2026-00596]
Journal Article
Pazan, F. ; Knorr, J. ; Weiss, C. ; et al
Longitudinal Non-interventional Changes of the FORTA Score are Associated with Changes of Cognitive and Physical Function Tests in Community-Dwelling Older People.
Listing tools were found to ameliorate drug treatment in older people; the FORTA (Fit-fOR-The-Aged) list is a clinically validated positive-negative list of medication appropriateness. Here, we retrospectively analyze longitudinal correlations between the FORTA score and key measures of physical and cognitive function in older people.504 participants of a multi-center cohort study (AgeCoDe/AgeQualiDe) for whom the FORTA score (sum of over- and under-treatment errors) had been assessed were studied at three follow-up (FU) time points (FU 6-8; mean age range 87.9-89.7 years); comparisons between data at these FUs separated by 10 months were available for 292-328 patients.The univariate analysis of the association between FORTA_Delta_76 (change of FORTA score between FU 6 and 7) and ADL (Activities of Daily Living)_Delta_76 (- 0.155, p < 0.01) and between FORTA_Delta_76 and MMSE (Mini-Mental State Examination)_Delta_76 (- 0.203, p < 0.01) revealed significant correlations. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-06-08 15:31 |
Detailed record - Similar records
|
2026-06-05 16:44 |
Detailed record - Similar records
|
|
|